Gut microbiota-derived metabolites as central regulators in metabolic disorders

2020/12/03 by Allison Agus, Karine Clément, Harry Sokol · 36 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Diet and metabolism studies #Gut microbiota and health #Liver Disease Diagnosis and Treatment

paper · pdf · doi:10.1136/gutjnl-2020-323071

openalex publication_date 2020/12/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31

Abstract

Metabolic disorders represent a growing worldwide health challenge due to their dramatically increasing prevalence. The gut microbiota is a crucial actor that can interact with the host by the production of a diverse reservoir of metabolites, from exogenous dietary substrates or endogenous host compounds. Metabolic disorders are associated with alterations in the composition and function of the gut microbiota. Specific classes of microbiota-derived metabolites, notably bile acids, short-chain fatty acids, branched-chain amino acids, trimethylamine N-oxide, tryptophan and indole derivatives, have been implicated in the pathogenesis of metabolic disorders. This review aims to define the key classes of microbiota-derived metabolites that are altered in metabolic diseases and their role in pathogenesis. They represent potential biomarkers for early diagnosis and prognosis as well as promising targets for the development of novel therapeutic tools for metabolic disorders.

Cited by

• Propionic Acid Driven by the <i>Lactobacillus johnsonii</i> Culture Supernatant Alleviates Colitis by Inhibiting M1 Macrophage Polarization by Modulating the MAPK Pathway in Mice
• Gut dysbiosis induced mitochondrial epigenetic programming as a determinant of ferroptosis susceptibility
• Linking the edible plant microbiome and human gut microbiome
• The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies
• Microbiota-Derived Metabolites in Developmental Programming: Bridging Early-Life Gut Microbiota to Childhood Metabolic Disorders
• Microbial community-scale metabolic modelling predicts personalized short-chain fatty acid production profiles in the human gut
• Multi‐Omics Signatures of Periodontitis and Periodontal Therapy on the Oral and Gut Microbiome
• From Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
• Gut‐on‐a‐chip platforms: Bridging in vitro and in vivo models for advanced gastrointestinal research
• Gut microbiota-associated metabolites in metabolic diseases and their impact from food processing
• Altitude adaptation: The unseen work of gut microbiota
• Effect of Diet and Dietary Components on the Composition of the Gut Microbiota. [europepmc]
• metaGEM: reconstruction of genome scale metabolic models directly from metagenomes. [europepmc]
• Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. [europepmc]
• Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health. [europepmc]
• Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals' Health and Disease. [europepmc]
• Promises of microbiome-based therapies. [europepmc]
• Trends in insulin resistance: insights into mechanisms and therapeutic strategy. [europepmc]
• Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands. [europepmc]
• The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management. [europepmc]
• Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout. [europepmc]
• Advances in multi-omics study of biomarkers of glycolipid metabolism disorder. [europepmc]
• Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease. [europepmc]
• Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health. [europepmc]
• Comparison of fecal and blood metabolome reveals inconsistent associations of the gut microbiota with cardiometabolic diseases. [europepmc]
• Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes. [europepmc]
• Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity. [europepmc]
• The Emerging Role of Raman Spectroscopy as an Omics Approach for Metabolic Profiling and Biomarker Detection toward Precision Medicine. [europepmc]
• Short-chain fatty acids in diseases. [europepmc]
• Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. [europepmc]
• Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. [europepmc]
• Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. [europepmc]
• Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation. [europepmc]
• Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications. [europepmc]
• Effects of Probiotics on Gut Microbiota: An Overview. [europepmc]
• Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. [europepmc]

Related

• Gut microbiome and health: mechanistic insights
• The architecture of gut microecological networks and the governance of host metabolic homeostasis
• Gut Microbiota in Cardiovascular Health and Disease
• Microbial metabolite indole-3-propionic acid supplementation does not protect mice from the cardiometabolic consequences of a Western diet
• Gut microbiota-associated metabolites in metabolic diseases and their impact from food processing